💨 Abstract

The FDA, under a Biden administration new Health Secretary, plans to expedite their efforts to evaluate the psychedelics drugs to be a therapeutic plan for the American people grappling with hard-to-treat conditions. This is the last push to push research on things like ibogaine which has a unique risk of irregular heart rhythm but beneficial effects to the patients.

Courtesy: WTOP Staff